Technology plays a vital role in the betterment of our society. Coupled with medicine, it can save countless lives while making living with chronic diseases easier. Cardiovascular diseases are a priority for us as they are globally the number 1 cause of death.
Congenital Heart Disease (CHD) affects approximately 40,000 (in US) and 1.3 million (globally) newborns each year. In the United States alone, the total number of patients in the affected by the CHD is now estimated to be 2.4 million patients. Of the 40,000 new patients found to have CHD each year in the US, an estimated 2,500 patients, primarily with conotruncal anomalies, have a defect that requires use of a substitute, non-native conduit artery in order to replace structures that are congenitally absent or hypoplastic. This incidence of new CHD patients and the relative distribution of defects has not changed over time and remains a function of the birth rate.